how long have glp 1 drugs been around GLP-1 and Type Diabetes: Less Insulin, Better Time in Range — What the Evidence Chart: 1 in 8 Americans
Description
doi:10.1136/bmj-2022-074068 Mller TD, Finan B, Bloom SR, et al
PMID: 34497589
Diab Res
Savchenko LG, Digtiar NI, Selikhova LG, Kaidasheva EI, Shlykova OA, Vesnina LE, et al
Several ongoing clinical trials, including the ELAD trial investigating liraglutide in Alzheimers disease and the Exenatide-PD trial in Parkinsons disease, aim to further clarify the neuroprotective potential of GLP-1RAs (Femminella et al
GLP-1s mimic these actions and, as theyre resistant to the enzyme DPP4, have a longer-lasting impact on our appetite
